These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30628055)

  • 1. A randomized phase II study evaluating vismodegib as neoadjuvant treatment of basal cell carcinoma preceding Mohs micrographic surgery: results and lessons learned.
    Soon SL; Ibrahim SF; Arron ST
    Br J Dermatol; 2019 Jul; 181(1):208-209. PubMed ID: 30628055
    [No Abstract]   [Full Text] [Related]  

  • 2. Vismodegib as a neoadjuvant treatment to Mohs surgery for aggressive basal cell carcinoma.
    Alcalay J; Tauber G; Fenig E; Hodak E
    J Drugs Dermatol; 2015 Mar; 14(3):219-23. PubMed ID: 25738842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Vismodegib and Mohs Micrographic Surgery for Locally Advanced Periocular Basal Cell Carcinoma.
    González AR; Etchichury D; Gil ME; Del Aguila R
    Ophthalmic Plast Reconstr Surg; 2019; 35(1):56-61. PubMed ID: 30444747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vismodegib as Eye-Sparing Neoadjuvant Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
    Angnardo L; Humeda Y; Alexandraki I; Wolfe CM; Cognetta AB
    J Drugs Dermatol; 2021 May; 20(5):552-554. PubMed ID: 33938701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective and Tolerable Treatment of Advanced Basal Cell Carcinoma With Vismodegib Despite Renal Insufficiency.
    Maul LV; Kähler KC; Hauschild A
    JAMA Dermatol; 2016 Dec; 152(12):1387-1388. PubMed ID: 26720040
    [No Abstract]   [Full Text] [Related]  

  • 6. An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma.
    Ally MS; Aasi S; Wysong A; Teng C; Anderson E; Bailey-Healy I; Oro A; Kim J; Chang AL; Tang JY
    J Am Acad Dermatol; 2014 Nov; 71(5):904-911.e1. PubMed ID: 24929884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vismodegib Efficacy in Advanced Basal Cell Carcinoma Maintained with 8-Week Dose Interruptions: A Model-Based Evaluation.
    Chanu P; Musib L; Wang X; Cheeti S; Girish S; Bruno R; Lu T; Reddy J; Jin JY; Caro I
    J Invest Dermatol; 2021 Apr; 141(4):930-933. PubMed ID: 32976880
    [No Abstract]   [Full Text] [Related]  

  • 8. Sonic Hedgehog Pathway Blockade After Surgical Debulk of Large Exophytic Basal Cell Carcinomas.
    Wirth PJ; Hobbs R; Billingsley E; Vidimos AT; Lam C
    Dermatol Surg; 2021 Aug; 47(8):1118-1119. PubMed ID: 34107497
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes for Basal Cell Carcinoma Treated With Vismodegib Extended Alternate Day Dosing.
    Routt E; Ratner D
    Dermatol Surg; 2020 Aug; 46(8):1109-1112. PubMed ID: 31274526
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma.
    Sagiv O; Nagarajan P; Ferrarotto R; Kandl TJ; Thakar SD; Glisson BS; Altan M; Esmaeli B
    Br J Ophthalmol; 2019 Jun; 103(6):775-780. PubMed ID: 30021814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience.
    Scalvenzi M; Villani A; Costa C; Cappello M
    Dermatol Ther; 2019 Jul; 32(4):e12971. PubMed ID: 31124200
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidermal cyst formation and hyperkeratosis in a patient treated with vismodegib for locally advanced Basal cell carcinoma.
    Reinders MG; Brinkhuizen T; Soetekouw PM; Kelleners-Smeets NW; Hamid MA; Mosterd K
    Acta Derm Venereol; 2015 May; 95(5):618-9. PubMed ID: 25425396
    [No Abstract]   [Full Text] [Related]  

  • 13. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
    Dessinioti C; Plaka M; Stratigos AJ
    Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative Use of Vismodegib.
    Lam C; Larson E; Vidimos AT; Billingsley EM
    Dermatol Surg; 2020 Feb; 46(2):272-276. PubMed ID: 30789523
    [No Abstract]   [Full Text] [Related]  

  • 15. Histopathology of Basal Cell Carcinoma After Treatment With Vismogedib.
    Tang JC; Buckel L; Hanke CW
    J Drugs Dermatol; 2019 Feb; 18(2):136-138. PubMed ID: 30794363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vismodegib Therapy for Periocular Basal Cell Carcinoma].
    Keserü M; Green S; Dulz S
    Klin Monbl Augenheilkd; 2017 Jan; 234(1):64-69. PubMed ID: 28135752
    [No Abstract]   [Full Text] [Related]  

  • 17. Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC).
    Kwon GP; Ally MS; Bailey-Healy I; Oro AE; Kim J; Chang AL; Aasi S; Tang JY
    J Am Acad Dermatol; 2016 Jul; 75(1):213-5. PubMed ID: 27317518
    [No Abstract]   [Full Text] [Related]  

  • 18. A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma.
    Sofen H; Gross KG; Goldberg LH; Sharata H; Hamilton TK; Egbert B; Lyons B; Hou J; Caro I
    J Am Acad Dermatol; 2015 Jul; 73(1):99-105.e1. PubMed ID: 25913533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological discrepancy of biopsy specimens compared to subsequent Mohs surgery or wide local excision specimens.
    Pham D; Tabba D; Zhou C; Chow C; Elsensohn A
    J Am Acad Dermatol; 2024 Sep; 91(3):518-519. PubMed ID: 38685403
    [No Abstract]   [Full Text] [Related]  

  • 20. Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.
    Basset-Seguin N; Hauschild A; Grob JJ; Kunstfeld R; Dréno B; Mortier L; Ascierto PA; Licitra L; Dutriaux C; Thomas L; Jouary T; Meyer N; Guillot B; Dummer R; Fife K; Ernst DS; Williams S; Fittipaldo A; Xynos I; Hansson J
    Lancet Oncol; 2015 Jun; 16(6):729-36. PubMed ID: 25981813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.